Rapid Micro Biosystems vs Alpha Teknova
Alpha Teknova is the larger business, with $40.5m of revenue in fiscal 2025 against $33.6m for Rapid Micro Biosystems (1.2 times as much). Rapid Micro Biosystems grew faster (19.7% against 7.4%). Alpha Teknova kept more of each dollar of sales as profit: a net margin of -42.6% against -140.3%.
| Latest fiscal year | Rapid Micro BiosystemsRPID, 2025 | Alpha TeknovaTKNO, 2025 |
|---|---|---|
| Revenue | $33.6m | $40.5m |
| Revenue growth | 19.7% | 7.4% |
| Net income | −$47.1m | −$17.3m |
| Operating margin | — | — |
| Net margin | -140.3% | -42.6% |
| Return on equity | -86.8% | -22.8% |
| Free cash flow | −$31.9m | −$9.8m |
| Cash | $20.0m | $5.9m |
| Total debt | $18.9m | $13.2m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 171 | 158 |
| Market value | $34.2m | $395m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | 13 (Weak) |
| Insider trades, 12 months | 0 buys, 14 sales | 2 buys, 0 sales |